Meeting the Challenge of Chemical Safety
When chemical companies develop new molecules, their top priorities are typically functionality, performance, and cost. Environmental safety and long-term toxicity often take a back seat—until problems arise. But with growing public awareness and concern over chemical exposure, particularly from endocrine-disrupting chemicals (EDCs), that paradigm is beginning to shift.
To address this need, a multidisciplinary team of scientists has developed a new framework to help chemists identify and eliminate endocrine-disrupting activity at the earliest stages of chemical design. This tool, called the Tiered Protocol for Endocrine Disruption (TiPED), guides users through a systematic approach to screening molecules before they reach the market.
What Is TiPED?
TiPED consists of five progressively complex tiers of assessment, ranging from computational modeling to full animal testing. It was created by a team of 23 scientists led by John Peterson Myers (Environmental Health Sciences), Karen Peabody O’Brien (Advancing Green Chemistry), and Thaddeus T. Schug (National Institute of Environmental Health Sciences). The protocol is designed to integrate green chemistry principles—safer, less toxic materials—with cutting-edge toxicology and predictive tools.
Why Focus on Endocrine Disruption?
Endocrine disruption refers to the interference of synthetic chemicals with hormone signaling in the body. Such disruptions are believed to contribute to a wide range of health problems, including cancer, infertility, obesity, diabetes, and developmental disorders in children. Unlike carcinogenicity, which is better regulated, EDCs remain a grey area in chemical safety due to the complexity of hormone systems and lack of standardized testing protocols.
Consumers increasingly demand transparency and safety in products they use every day—from plastics to personal care items—creating pressure for companies to develop bisphenol A-free, phthalate-free, and otherwise non-toxic alternatives. Yet, until now, companies lacked a comprehensive design tool to ensure products are free of EDCs from the start.
The Five Tiers of TiPED
The TiPED framework allows chemists to begin at any tier based on existing knowledge of a molecule. Each level offers pass/fail checkpoints and opportunities to refine or redesign the chemical in question.
- Tier 1: Computational modeling using statistical and mathematical predictions based on molecular structure and chemical properties.
- Tier 2: In vitro biochemical and cell-based assays to determine whether a chemical binds to known hormone receptors.
- Tier 3: Cell and tissue assays to test for biological outcomes such as cell division or apoptosis related to endocrine signaling. Includes liver metabolism studies.
- Tier 4: Whole-organism testing in aquatic animals like fish and frogs to assess multi-hormone endpoints.
- Tier 5: Mammalian testing (typically in rodents) to simulate human biological responses and confirm endocrine safety.
If a chemical fails any tier, it is sent back for redesign. The goal is not simply to test chemicals after development—as is done with drugs and pesticides—but to build safety into the molecule from the ground up.
Bridging Chemistry and Toxicology
One of the challenges TiPED addresses is that chemists are rarely trained toxicologists. The tool is intentionally structured to help non-experts navigate a complex field, select appropriate assays, and collaborate with specialists when needed. This approach can prevent costly product failures or market withdrawals in the future.
“Chemists can design molecules to not act like hormones,” says Myers. “But they just haven’t been asked to focus on doing it.”
Next Steps and Industry Adoption
TiPED is a living protocol that will evolve with new scientific discoveries. Myers emphasizes that while it can’t yet detect every possible EDC mechanism, updates and improvements will be added via its peer-reviewed platform,TiPEDinfo.com.
Organizations like GreenBlue and Advancing Green Chemistry believe TiPED has the potential to transform how companies approach product safety. “It’s a great tool to eliminate unintended consequences early in the design stage,” notes GreenBlue’s executive director Nina Goodrich.
The TiPED team is now preparing to work with select companies for pilot testing and to gather feedback for scaling up. Their goal is to embed this framework into mainstream chemical design, making safety a default rather than an afterthought.
Conclusion
TiPED represents a critical step toward safer, more sustainable chemistry. By empowering chemists to identify endocrine-disrupting activity before a product reaches consumers, it offers not just a pathway to regulatory compliance—but a chance to restore public trust and improve human health through thoughtful innovation.